# An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

> **NCT01286090** · PHASE4 · TERMINATED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 4 (actual)

## Conditions studied

- Gastroparesis
- Diabetes Mellitus

## Interventions

- **DRUG:** Cisapride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01286090
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Sponsor request
- **Last updated:** 2011-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01286090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01286090, "An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01286090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*